Aveir AR Coverage With Evidence Development (CED) Study

Recruiting now

Conditions studied: Cardiac Pacemaker, Arrhythmia, Bradycardia

In brief

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Atrial Leadless Pacemaker device (aka Aveir™ AR LP system).

Key facts

Study ID

NCT06100770

Run by

Abbott Medical Devices

People needed

586

Starts

2024-01-18

Expected to finish

2031-01-01

Last updated by the study team

2025-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Medicare beneficiaries implanted with an Aveir AR leadless pacemaker on or after the study start date (i.e., the date of Aveir AR market approval) will be included in the study.
• OR
• Medicare beneficiaries implanted with a full system (e.g. lead and generator) single chamber atrial transvenous pacemaker on or after the study start date

You may not qualify if…

• None

Where it is running

• Abbott — Sylmar, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.